For research use only — not for human consumption

GLP-3

GLP-1/GIP/Glucagon Triple Agonist

Price range: $180.00 through $370.00

Single vials

SizePer vialPer mg
10 mg$180.00$18.00
15 mg$210.00$14.00
20 mg$290.00$14.50
30 mg$370.00$12.33

Every listing is a single vial. The per-mg figure is shown for comparison only.

98% minimum purity, verified by HPLC.

For in vitro research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.

Request Certificate of AnalysisIssued per batch. Allow 1–2 business days.

Lyophilised powder in a single sealed vial. 98% minimum purity, verified by HPLC. For in vitro research and laboratory use only.

Buy more, save more

Applies per compound and size. Different products or sizes do not combine toward a tier.

SKU: ALW-GLP3
Category:

About this compound

GLP-3 is a synthetic peptide acting as a triple agonist at the GLP-1, GIP and glucagon receptors. It represents a novel research compound in the incretin mimetic class currently under laboratory investigation.

GLP-3 supplied as lyophilised powder in a single sealed vial. Available in 10 mg, 15 mg, 20 mg, 30 mg.

Every batch is assayed by an accredited third-party laboratory to a 98% minimum purity standard, verified by HPLC. Certificates of Analysis are issued per batch and supplied on request — use the Request Certificate of Analysis link on this page and quote your order number.

Supplied to registered research counterparties only. For in vitro research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.

Quick facts

Class
GLP-1/GIP/Glucagon Triple Agonist
Format
Lyophilised powder
Sizes
10 mg, 15 mg, 20 mg, 30 mg
Supplied as
Single vial
Purity
98% minimum, HPLC verified
Category
Metabolic
Use
Research use only

Research

  1. Retatrutide-A Game Changer in Obesity PharmacotherapyBiomolecules · 2025
  2. Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 TrialThe New England journal of medicine · 2023
  3. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trialNature medicine · 2024

Peer-reviewed literature referencing this compound, listed for reference. Aletheia Wellness is not affiliated with these publications and makes no claim based on them.

Related products

  • 5-Amino-1MQ

    NNMT Inhibitor

    Price range: $80.00 through $170.00
  • AOD-9604

    hGH Fragment (176-191)

    Price range: $110.00 through $200.00
  • Cagrilintide

    Long-Acting Amylin Analogue

    Price range: $140.00 through $250.00
  • CagriSema

    Amylin Analogue + GLP-1 Agonist Blend

    Price range: $135.00 through $200.00
  • Dulaglutide

    GLP-1 Receptor Agonist, Fc Fusion

    Price range: $180.00 through $240.00